Compare Mirae Asset Healthcare Fund vs SBI Healthcare Opportunities Fund
Risk | Very High | Very High |
Rating | 2.0 | 4.0 |
Min SIP Amount | ₹99 | ₹500 |
Expense Ratio | 1.93 | 1.93 |
NAV | ₹37.73 | ₹420.93 |
Fund Started | 11 Jun 2018 | 04 Jun 1999 |
Fund Size | ₹2770.84 Cr | ₹3989.42 Cr |
Exit Load | Exit load of 1% if redeemed within 1 year. | Exit load of 0.50% if redeemed within 15 days |
Risk
Very High
Very High
Rating
2.0
4.0
Min SIP Amount
₹99
₹500
Expense Ratio
1.93
1.93
NAV
₹37.73
₹420.93
Fund Started
11 Jun 2018
04 Jun 1999
Fund Size
₹2770.84 Cr
₹3989.42 Cr
Exit Load
Exit load of 1% if redeemed within 1 year.
Exit load of 0.50% if redeemed within 15 days
1 Year | 1.61% | 0.20% |
3 Year | 21.14% | 23.54% |
5 Year | 14.62% | 15.54% |
1 Year
1.61%
0.20%
3 Year
21.14%
23.54%
5 Year
14.62%
15.54%
Equity | 99.46% | 96.59% |
Cash | 0.54% | 3.34% |
Equity
99.46%
96.59%
Cash
0.54%
3.34%
Top 10 Holdings |
|
|
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 12.44% |
Divi's Laboratories Ltd. | 8.57% |
Glenmark Pharmaceuticals Ltd. | 6.91% |
Apollo Hospitals Enterprise Ltd. | 5.80% |
Cipla Ltd. | 5.55% |
Lupin Ltd. | 5.23% |
Dr. Reddy's Laboratories Ltd. | 4.34% |
Aurobindo Pharma Ltd. | 4.24% |
Fortis Healthcare Ltd. | 4.22% |
Ipca Laboratories Ltd. | 3.46% |
Sun Pharmaceutical Industries Ltd. | 11.64% |
Divi's Laboratories Ltd. | 7.05% |
Max Healthcare Institute Ltd. | 5.24% |
Lupin Ltd. | 4.44% |
Laurus Labs Ltd. | 3.89% |
Torrent Pharmaceuticals Ltd. | 3.86% |
Acutaas Chemicals Ltd. | 3.85% |
Cipla Ltd. | 3.79% |
Lonza Group Ag | 3.63% |
Biocon Ltd. | 3.16% |
Name | - | - |
Start Date | - | - |
Name
-
-
Start Date
-
-
Description | The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India. | The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space. |
Launch Date | 11 Jun 2018 | 04 Jun 1999 |
Description
The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
11 Jun 2018
04 Jun 1999